DRUG-THERAPY IN RENAL-FAILURE

被引：27

作者：

REIDENBERG, MM ^{[1
]}

DRAYER, DE ^{[1
]}

机构：

[1] CORNELL UNIV, DEPT MED, NEW YORK, NY 10021 USA

来源：

关键词：

D O I：

10.1146/annurev.pa.20.040180.000401

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：45 / 54

页数：10

共 74 条

[1] AFFRIME MB, J DIALYSIS
[2] Anderson RJ, 1976, CLIN USE DRUGS RENAL
[3] ANDREASEN F, 1974, ACTA PHARMACOL TOX, V35, P49
[4] ATKINSON AJ, 1977, CLIN PHARMACOL THER, V21, P575
[5] IMPAIRMENT OF COGNITIVE FUNCTION ASSOCIATED WITH HYDROXYAMYLOBARBITONE ACCUMULATION IN PATIENTS WITH RENAL-INSUFFICIENCY
BALASUBR.
SIMONS, PJG
POHL, JEF
MAWER, GE
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1972, 45 (02) : 360 - +
[6] HISTAMINE METABOLISM IN HUMAN DISEASE
BEALL, GN
VANARSDEL, PP
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1960, 39 (04) : 676 - 683
[7] GUIDELINES FOR DRUG-THERAPY IN RENAL-FAILURE
BENNETT, WM
SINGER, I
GOLPER, T
FEIG, P
COGGINS, CJ
[J]. ANNALS OF INTERNAL MEDICINE, 1977, 86 (06) : 754 - 783
[8] BENNETT WM, 1978, DRUGS RENAL DISEASE, P21
[9] BIANCHETTI G, 1976, Clinical Pharmacokinetics, V1, P373, DOI 10.2165/00003088-197601050-00004
[10] BOOBIS SW, 1977, CLIN PHARMACOL THER, V22, P147